Omthera Pharmaceuticals' Series B - II Round

Omthera Pharmaceuticals raised a round of funding on January 09, 2012.

Omthera Pharmaceuticals is a specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Omthera is dedicated to developing therapies for pati…

Articles about Omthera Pharmaceuticals' Series B - II Round: